Literature DB >> 23183204

Characterization of group B streptococcus isolated from women in Saitama city, Japan.

Hiroyuki Ueno1, Yoshihiko Yamamoto, Akiko Yamamichi, Koji Kikuchi, Sumie Kobori, Motonobu Miyazaki.   

Abstract

Streptococcus agalactiae (group B streptococcus; GBS) is a common cause of neonatal sepsis and meningitis. Intrapartum antibiotic prophylaxis is effective in reducing neonatal GBS disease. Penicillin is recommended for intrapartum antibiotic prophylaxis; however, other antibiotics are administered to pregnant women with penicillin allergy. Serotyping and antibiotic susceptibility testing were performed on 376 GBS isolates collected from vaginal swabs in Saitama City. Of the 376 isolates, 328 (87.2%) were obtained from obstetrics and gynecology clinics. Although approximately 80% of the isolates (299/376) were from women of reproductive age (age, 15-49 years), no definite information on their pregnancy status was obtained. The most frequent serotype was V (19.1%) followed by Ib (18.6%), III (16.2%), VI (14.9%), and Ia (14.6%). None of the isolates were resistant to penicillins and cephalosporins. Isolates that were resistant to erythromycin (12.8%), clindamycin (9.0%), ofloxacin (19.4%), levofloxacin (18.4%), and tetracycline (46.5%) were detected. There was a high prevalence of resistance to erythromycin (39.3%) and clindamycin (27.9%) in serotype III. In addition, almost all serotype Ib isolates were resistant to ofloxacin and levofloxacin (both, 91.4%). Pulsed-field gel electrophoresis analysis on certain GBS isolates (serotype Ib, III, and V) indicated that there was genetic diversity among the resistant isolates obtained from a limited area of Japan. In conclusion, present intrapartum antibiotic prophylaxis with penicillins would be effective in Japan; however, performing susceptibility testing before administering other antibiotics is important in order to ensure activity against the relevant isolate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183204     DOI: 10.7883/yoken.65.516

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  9 in total

1.  Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

Authors:  G Piccinelli; F Gargiulo; S Corbellini; G Ravizzola; C Bonfanti; A Caruso; M A De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

2.  High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae Strains Isolated from Clinical Samples in Tehran, Iran.

Authors:  Mohammad Emaneini; Akbar Mirsalehian; Reza Beigvierdi; Abbas Ali Imani Fooladi; Fatemeh Asadi; Fereshteh Jabalameli; Morovat Taherikalani
Journal:  Maedica (Buchar)       Date:  2014-06

3.  Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors:  A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-28       Impact factor: 3.267

4.  Association between capsular serotype V and macrolide resistance in group B Streptococcus.

Authors:  P Sendi; S Fröhlicher
Journal:  Epidemiol Infect       Date:  2014-06-05       Impact factor: 4.434

5.  Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China.

Authors:  Ping Wang; Jing-jing Tong; Xiu-hua Ma; Feng-li Song; Ling Fan; Cui-mei Guo; Wei Shi; Sang-jie Yu; Kai-hu Yao; Yong-hong Yang
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

6.  Colonization prevalence and antibiotic susceptibility of Group B Streptococcus in pregnant women over a 6-year period in Dongguan, China.

Authors:  Wenjing Ji; Lihua Zhang; Zhusheng Guo; Shujin Xie; Weiqing Yang; Junjian Chen; Jiamin Wang; Zhiqin Cheng; Xin Wang; Xuehai Zhu; Jianwen Wang; Haiqing Wang; Juan Huang; Ning Liang; David J McIver
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

7.  Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women.

Authors:  Lindsey R Burcham; Brady L Spencer; Lauryn R Keeler; Donna L Runft; Kathryn A Patras; Melody N Neely; Kelly S Doran
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

8.  Molecular characterization and antimicrobial resistance of Streptococcus agalactiae isolated from pregnant women in Japan, 2017-2021.

Authors:  Mitsuyo Kawaguchiya; Noriko Urushibara; Meiji Soe Aung; Shigeki Shimada; Mayumi Nakamura; Masahiko Ito; Satoshi Habadera; Nobumichi Kobayashi
Journal:  IJID Reg       Date:  2022-07-14

9.  Molecular Characterization of Streptococcus agalactiae Causing Community- and Hospital-Acquired Infections in Shanghai, China.

Authors:  Haoqin Jiang; Mingliang Chen; Tianming Li; Hong Liu; Ye Gong; Min Li
Journal:  Front Microbiol       Date:  2016-08-30       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.